The lack of precise tools for evaluating individual disease biology for patients with autoimmune and inflammatory diseases has limited the ability to tailor treatment to individuals rather than the average characteristics of the population. To address this gap in rheumatoid arthritis, for example, quantitative tests that objectively characterize disease biology could complement current symptom-focused approaches, enabling better management and further improving patient outcomes.
Crescendo Bioscience is a CLIA-certified, CAP accredited, molecular diagnostics laboratory focused on rheumatology. Crescendo is developing quantitative, objective, biology-based tests to provide rheumatologists with deeper clinical insights to help enable more effective management of patients with autoimmune and inflammatory diseases.
Crescendo Bioscience is building a comprehensive understanding of the biology underlying rheumatoid arthritis and other rheumatic diseases, including the interrogation of protein, gene expression and genetic biomarkers, to provide information to help guide treatment for individual patients.